120TiP Conversion of response to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: A randomized phase Ib/IIa trial. (December 2022) - Borgers, J.S.W.; Burgers, F.; Terveer, E.M.; van Leerdam, M.; Korse, T.M.; Kessels, R.; Henderickx, J.G.E.; Flohil, C.C.; van Dijk, M.; Keller, J.J.; Verspaget, H.W.; Kuijper, E.J.; et al.